These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10166629)

  • 1. Measuring treatment effectiveness. Part two: Newly emerging outcomes databases for individual practitioners.
    Zarin DA; Pincus HA; West J; Ragusea SA
    Behav Healthc Tomorrow; 1997 Apr; 6(2):45-7. PubMed ID: 10166629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring treatment effectiveness. Part one: Newly emerging outcomes databases for organizations.
    Flynn L; Zieman GL; Kramer TL; Daniels AS; Lunghofer LA; Hughes R; Bologna NC; Stutrud M
    Behav Healthc Tomorrow; 1997 Apr; 6(2):37-44. PubMed ID: 10166628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Culture shock and synergy. Academic/managed care/corporate alliances in outcomes management.
    Berman WH; Darling H; Hurt SW; Hunkeler EM
    Behav Healthc Tomorrow; 1994; 3(3):23-9. PubMed ID: 10141017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can outcomes measurement make a difference?
    Durrell J
    Behav Healthc Tomorrow; 1995; 4(3):80, 78-9. PubMed ID: 10143425
    [No Abstract]   [Full Text] [Related]  

  • 5. Dialogue. The rush to measure outcomes: help or hazard? The shift from efficacy to effectiveness research to demonstrate value.
    Sederer LI
    Behav Healthc Tomorrow; 1995; 4(3):40, 43-4. PubMed ID: 10143418
    [No Abstract]   [Full Text] [Related]  

  • 6. Quality initiatives and the power of the database: where we stand.
    Kouchoukos NT
    Ann Thorac Surg; 1995 Nov; 60(5):1526-9. PubMed ID: 8526680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to involve staff in developing an outcomes-oriented organization.
    Koch R; Cairns JM; Brunk M
    Behav Healthc Tomorrow; 1998 Jun; 7(3):29-31, 62. PubMed ID: 10180301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Outcomes Roundtable. Developing, evaluating, and disseminating outcomes monitoring technology.
    Shern DL; Flynn LM
    Behav Healthc Tomorrow; 1996 Jun; 5(3):24-30. PubMed ID: 10158039
    [No Abstract]   [Full Text] [Related]  

  • 9. A framework for assessing the effectiveness, efficiency, and equity of behavioral healthcare.
    Aday LA; Begley CE; Lairson DR; Slater CH; Richard AJ; Montoya ID
    Am J Manag Care; 1999 Jun; 5 Spec No():SP25-44. PubMed ID: 10538859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dialogue. Promises and pitfalls of the newly emerging outcomes databases.
    Steinwachs DM; Brill PL; Daniels A; Kearney W
    Behav Healthc Tomorrow; 1997 Apr; 6(2):48-54. PubMed ID: 10166630
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcomes research: collaboration among academic researchers, managed care organizations, and pharmaceutical manufacturers.
    Kong SX; Wertheimer AI
    Am J Manag Care; 1998 Jan; 4(1):28-34. PubMed ID: 10179904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Databases for outcomes research: what has 10 years of experience taught us?
    Bosco L
    Pharmacoepidemiol Drug Saf; 2001; 10(5):445-55. PubMed ID: 11802591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-care outcomes research. Texas Medical Association Council on Scientific Affairs.
    Burnside JW
    Tex Med; 1996 Jul; 92(7):61-71. PubMed ID: 8763251
    [No Abstract]   [Full Text] [Related]  

  • 16. [Background and possible use of ROM in mental health care].
    Nugter MA; Buwalda VJ
    Tijdschr Psychiatr; 2012; 54(2):111-20. PubMed ID: 22331531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provider type and depression treatment adequacy.
    Kniesner TJ; Powers RH; Croghan TW
    Health Policy; 2005 Jun; 72(3):321-32. PubMed ID: 15862640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why focus on outcomes data?
    Cagney T; Woods DR
    Behav Healthc Tomorrow; 1994; 3(3):65-7. PubMed ID: 10141025
    [No Abstract]   [Full Text] [Related]  

  • 19. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.